ARTICLE | Clinical News

Dronabinol data

April 3, 1995 7:00 AM UTC

The Buffalo Grove, Ill., company reported that the drug gave statistically significant increases in self-ratings of appetite in 88 evaluable patients.

As published in the Journal of Pain and Symptom Management, placebo was associated with continued weight loss, while those patients taking THC had a small average weight gain at the end of the six-week trial. The dose was 2.5 mg twice a day. ...